BCL2 and Child Behaviour Checklist assessment: In summary, our results – albeit confined to a limited number of patients and the analysis of only two pro- or antiapoptotic signalling pathways, namely RKIP and bcl-2 – raise the hypothesis that the modulation of regulators of apoptosis may be important for the clinical effect of rituximab on CBCL.